IPO registrations (S-1, F-1) · Registrants
Kiromic Biopharma, Inc.
- SEC CIK
- 1792581 · filings on EDGAR ↗
- Former names
- Kiromic, Inc. (2019–2019)
- Registration
- Form S-1, first filed 2020-05-11, last 2025-02-19; 6 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2020-10-16; declared effective 2020-10-15; withdrawal requested 2022-08-19
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 7707 FANNIN ST., SUITE 140, Houston, TX 77054
- EIN
- 46-4762913
- EDGAR entity type
- operating
- Insiders and CEO pay
- Kiromic Biopharma, Inc. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2020-10-06)
- Final price
- $12.00 per share, within the range (424B4 filed 2020-10-16, an initial public offering)
- Shares sold
- 1,250,000
- Gross proceeds
- $15,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol KRBP
- Lead underwriters
- ThinkEquity
- Syndicate
- Paulson Investment Company, LLC (331,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: KIROMIC BIOPHARMA, INC Fuzzy (name and state)
- Form 5500 plan sponsor: KIROMIC BIOPHARMA, INC. EXACT (EIN (EXACT))
- Federal award recipient: KIROMIC BIOPHARMA, INC Fuzzy (name and state)
- SEC filer: Kiromic Biopharma, Inc. EXACT (CIK (EXACT))
Filings 21
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-05-11 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001193125-20-138735 ↗ |
| 2020-06-26 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001047469-20-003880 ↗ |
| 2020-07-13 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001104659-20-082923 ↗ |
| 2020-08-05 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001047469-20-004406 ↗ |
| 2020-08-24 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001047469-20-004697 ↗ |
| 2020-09-03 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001047469-20-004750 ↗ |
| 2020-10-06 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001047469-20-005120 ↗ |
| 2020-10-15 | EFFECT | EFFECT (declared effective) | Kiromic Biopharma, Inc. | 9999999995-20-002853 ↗ |
| 2020-10-16 | 424B4 | 424B4 (final prospectus) | Kiromic Biopharma, Inc. | 0001047469-20-005215 ↗ |
| 2021-06-25 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001104659-21-085768 ↗ |
| 2021-06-29 | EFFECT | EFFECT (declared effective) | Kiromic Biopharma, Inc. | 9999999995-21-002591 ↗ |
| 2021-06-30 | 424B4 | 424B4 (final prospectus) | Kiromic Biopharma, Inc. | 0001104659-21-087657 ↗ |
| 2022-06-27 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001104659-22-074818 ↗ |
| 2022-07-13 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001104659-22-079590 ↗ |
| 2022-08-19 | RW | RW (withdrawal request) | Kiromic Biopharma, Inc. | 0001104659-22-092952 ↗ |
| 2023-05-15 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001558370-23-009967 ↗ |
| 2023-05-19 | EFFECT | EFFECT (declared effective) | Kiromic Biopharma, Inc. | 9999999995-23-001487 ↗ |
| 2023-06-29 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001558370-23-011583 ↗ |
| 2024-04-10 | RW | RW (withdrawal request) | Kiromic Biopharma, Inc. | 0001558370-24-004929 ↗ |
| 2025-01-17 | S-1 | S-1 (registration) | Kiromic Biopharma, Inc. | 0001437749-25-001415 ↗ |
| 2025-02-19 | S-1/A | S-1/A (amendment) | Kiromic Biopharma, Inc. | 0001437749-25-004407 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-06 | S-1/A | registration statement | $12.00–$14.00 | 1,153,847 | - | Nasdaq KRBP | 2 | primary document; range, shares headline, cover names 2 | document ↗ | |
| 2020-10-16 | 424B4 | final prospectus | $12.00 | 1,250,000 | $15,000,000 | Nasdaq KRBP | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BERSANI PIETRO | Director; Director,Officer | CEO; Chief Executive Officer | 6 | 2020–2024 | |
| Chiriva Internati Maurizio | Director,Officer | Chairman, CEO, and President; CHIEF EXECUTIVE OFFICER | 2 | 2020–2021 | |
| Cicchetti Americo | Director | 2 | 2020–2022 | ||
| Dahlbeck Scott | Officer | Chief Medical Officer; Chief of Staff | 3 | 2020–2022 | |
| Rotino Gianluca | Director,Officer | CHIEF STRAT & INNOV OFFICER; CSIO; CSO AND CIO; See Remarks | 4 | 2020–2021 | |
| Tontat Tony | Director,Officer | CFO; CFO AND COO; CFO & COO | 3 | 2020–2021 | |
| NAGEL MICHAEL | Director | 5 | 2020–2024 | ||
| Schneider Jerry A. | Director | 2 | 2020–2021 | ||
| Nunez Ignacio | Officer | CHIEF OPERAT. AND MANUF. OFFI.; See Remarks | 2 | 2021 | |
| Ryan Michael Charles | Officer | Chief Technology Officer; See Remarks | 2 | 2021 | |
| Clark Daniel Grant | Officer | Chief Financial Officer; Interim CFO | 2 | 2021–2022 | |
| Reeves Karen | Director | 2 | 2022 | ||
| Tirelli Francis X | Director | 2 | 2022 | ||
| Misajon Pamela | Director | 5 | 2023–2024 | ||
| Catlin Michael | Director | 3 | 2023–2024 | ||
| Hungerford Brian | Officer | CFO; Chief Financial Officer | 7 | 2023–2024 | |
| Mirandola Leonardo | Officer | CSO | 1 | 2024 | |
| Ralston Shannon | TenPercentOwner | 2 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | KIROMIC BIOPHARMA, INC | TX | State business registries | name and state |
| Plan sponsor | KIROMIC BIOPHARMA, INC. | TX | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | KIROMIC BIOPHARMA, INC | TX | Federal spending (USAspending) | name and state |
| SEC filer | Kiromic Biopharma, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Kiromic Biopharma, Inc. | TX | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | KIROMIC BIOPHARMA, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), TX first:
- ILEX ONCOLOGY INC TX
- HEMOBIOTECH, INC. TX
- Peloton Therapeutics, Inc. TX
- Alpha Cognition Inc. TX
- Instil Bio, Inc. TX
- Taysha Gene Therapies, Inc. TX
- CG Oncology, Inc. TX
- Voyager Acquisition Corp./Cayman Islands TX
- STEM CELL INNOVATIONS, INC. TX
- REPROS THERAPEUTICS INC. TX
In other datasets, the same topic (Health) in TX:
- Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health